Issue 43, 2020

Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective

Abstract

The application of mesoporous silica nanoparticles (MSNs) as drug delivery systems to deliver drugs, proteins, and genes has expanded considerably in recent years, using in vitro and animal studies. For future translation to clinical applications, the biological safety aspects of MSNs must be considered carefully. This paper reviews the biosafety of MSNs, examining key issues such as biocompatibility, effects on immune cells and erythrocytes, biodistribution, biodegradation and clearance, and how these vary depending on the effects of the physical and chemical properties of MSNs such as particle size, porosity, morphology, surface charge, and chemical modifications. The future use of MSNs as a delivery system must extend beyond what has been learnt thus far using rodent animal models to encompass larger animals.

Graphical abstract: Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective

Article information

Article type
Review Article
Submitted
31 juil. 2020
Accepted
15 sept. 2020
First published
15 sept. 2020

J. Mater. Chem. B, 2020,8, 9863-9876

Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective

S. Hosseinpour, L. J. Walsh and C. Xu, J. Mater. Chem. B, 2020, 8, 9863 DOI: 10.1039/D0TB01868F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements